• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用CD34免疫组织化学法评估非小细胞肺癌中的血管生成

Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.

作者信息

Bing Zhu, Jian-ru Yang, Yao-quan Jiang, Shi-feng Chen

机构信息

Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Chongqing Medical University, Linjiang Road 74, Yuzhong District, Chongqing, 400010, China,

出版信息

Cell Biochem Biophys. 2014 Sep;70(1):327-31. doi: 10.1007/s12013-014-9916-5.

DOI:10.1007/s12013-014-9916-5
PMID:24676677
Abstract

The objective of the study was to investigate angiogenesis in non-small lung cancer by measuring the expression of CD34. Immunohistochemistry was used to detect CD34 at the endothelial cell surface in 81 surgically resected non-small cell lung cancer specimens. CD34 immunohistochemistry had high specificity and sensitivity with minimal background, which enabled efficient identification of CD34-positive staining. Statistical analysis showed that increased microvessel density (MVD) was closely correlated to tumor progression as reflected by the clinical stage (P < 0.05). However, MVD was not significantly associated with lymph node metastasis and other clinical and pathological features (P > 0.05). In conclusion, microvascular density may play an important role in the development and progression of lung cancer.

摘要

本研究的目的是通过测量CD34的表达来调查非小细胞肺癌中的血管生成。采用免疫组织化学方法检测81例手术切除的非小细胞肺癌标本内皮细胞表面的CD34。CD34免疫组织化学具有高特异性和敏感性,背景极小,能够有效识别CD34阳性染色。统计分析表明,微血管密度(MVD)增加与临床分期所反映的肿瘤进展密切相关(P < 0.05)。然而,MVD与淋巴结转移及其他临床和病理特征无显著相关性(P > 0.05)。总之,微血管密度可能在肺癌的发生和发展中起重要作用。

相似文献

1
Evaluation of angiogenesis in non-small cell lung carcinoma by CD34 immunohistochemistry.应用CD34免疫组织化学法评估非小细胞肺癌中的血管生成
Cell Biochem Biophys. 2014 Sep;70(1):327-31. doi: 10.1007/s12013-014-9916-5.
2
[Expression of erythropoietin and erythropoietin receptor in non-small cell lung cancer and its correlation with microvessel density].促红细胞生成素及促红细胞生成素受体在非小细胞肺癌中的表达及其与微血管密度的相关性
Zhonghua Zhong Liu Za Zhi. 2012 Aug;34(8):605-8. doi: 10.3760/cma.j.issn.0253-3766.2012.08.010.
3
Evaluation of angiogenesis with the expression of VEGF and CD34 in human non-small cell lung cancer.通过检测VEGF和CD34表达评估人非小细胞肺癌中的血管生成情况。
J Exp Clin Cancer Res. 2007 Sep;26(3):375-8.
4
Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.肿瘤内微血管密度对接受化疗联合贝伐珠单抗治疗的晚期非小细胞肺癌患者的预测价值。
J Thorac Oncol. 2012 Jan;7(1):71-5. doi: 10.1097/JTO.0b013e31823085f4.
5
JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.JAK2/STAT3 信号通路激活通过上调非小细胞肺癌中的 VEGF 和 bFGF 介导肿瘤血管生成。
Lung Cancer. 2011 Sep;73(3):366-74. doi: 10.1016/j.lungcan.2011.01.002. Epub 2011 Feb 17.
6
Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.非小细胞肺癌中血管生成的评估:抗CD34抗体与抗CD105抗体的比较。
Clin Cancer Res. 2001 Nov;7(11):3410-5.
7
[Vascular endothelial growth factor expression and microvessel density in stage I-II non-small cell lung cancer and their prognostic significances].I-II期非小细胞肺癌中血管内皮生长因子表达及微血管密度及其预后意义
Ai Zheng. 2005 Jul;24(7):865-9.
8
Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.非小细胞肺癌患者循环内皮祖细胞数量和肿瘤内微血管密度:腺癌组织学亚型之间血管生成状态的差异。
J Thorac Oncol. 2012 Mar;7(3):503-11. doi: 10.1097/JTO.0b013e318241780e.
9
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.VEGF、CD31、CD34和CD105表达及肿瘤血管侵犯对IB-IIA期非小细胞肺癌根治术后的预后影响
J Clin Pathol. 2004 Jun;57(6):591-7. doi: 10.1136/jcp.2003.013508.
10
Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer.核热休克因子1的上调促进非小细胞肺癌患者的肿瘤血管生成和不良生存。
Ann Thorac Surg. 2015 Aug;100(2):465-72. doi: 10.1016/j.athoracsur.2015.03.021. Epub 2015 Jun 19.

引用本文的文献

1
CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence.肺腺癌微血管的CD34评估及其微血管密度可预测术后肿瘤复发。
Pathol Oncol Res. 2025 Jan 20;31:1611985. doi: 10.3389/pore.2025.1611985. eCollection 2025.
2
Expression and clinical significance of SYNE3 in non-small cell lung cancer.SYNE3在非小细胞肺癌中的表达及临床意义
Am J Transl Res. 2024 Sep 15;16(9):4436-4449. doi: 10.62347/ZHBP7145. eCollection 2024.
3
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an mutation.
微血管面积与肿瘤面积之比对携带EGFR突变的非小细胞肺癌患者EGFR-TKI治疗反应的负面影响。
J Thorac Dis. 2024 Feb 29;16(2):1151-1160. doi: 10.21037/jtd-23-1723. Epub 2024 Feb 26.
4
Evaluation of Angiogenesis and Pathological Classification of Extrahepatic Cholangiocarcinoma by Dynamic MR Imaging for E-Healthcare.动态磁共振成像在电子医疗中的应用评价肝外胆管癌的血管生成和病理分类。
J Healthc Eng. 2021 Oct 11;2021:8666498. doi: 10.1155/2021/8666498. eCollection 2021.
5
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma.免疫疗法与肿瘤微环境靶向治疗:原发性肺NUT癌的现状与新见解
Front Oncol. 2021 Sep 30;11:690115. doi: 10.3389/fonc.2021.690115. eCollection 2021.
6
CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer.CD34 和 Bcl-2 作为预测宫颈癌新辅助化疗疗效的标志物。
Arch Gynecol Obstet. 2021 Aug;304(2):495-501. doi: 10.1007/s00404-020-05921-8. Epub 2021 Jan 3.
7
Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer.表面工程化的纳米结构脂质载体系统用于非小细胞肺癌的协同组合肿瘤治疗。
Drug Deliv Transl Res. 2021 Oct;11(5):2030-2051. doi: 10.1007/s13346-020-00866-6. Epub 2020 Nov 19.
8
Presence of intra-tumoral CD61+ megakaryocytes predicts poor prognosis in non-small cell lung cancer.肿瘤内CD61+巨核细胞的存在预示非小细胞肺癌预后不良。
Transl Lung Cancer Res. 2019 Aug;8(4):323-331. doi: 10.21037/tlcr.2019.08.23.
9
Electroacupuncture on ST36 and GB39 Acupoints Inhibits Synovial Angiogenesis via Downregulating HIF-1/VEGF Expression in a Rat Model of Adjuvant Arthritis.电针足三里和足临泣穴通过下调佐剂性关节炎大鼠模型中HIF-1/VEGF的表达抑制滑膜血管生成
Evid Based Complement Alternat Med. 2019 Jun 16;2019:5741931. doi: 10.1155/2019/5741931. eCollection 2019.
10
Microvascular proliferation is associated with aggressive tumour features and reduced survival in lung adenocarcinoma.微血管增殖与肺腺癌的侵袭性肿瘤特征及生存率降低相关。
J Pathol Clin Res. 2017 Sep 12;3(4):249-257. doi: 10.1002/cjp2.78. eCollection 2017 Oct.